Skip to content
Screener
Alexandria Real Estate Equities logo

Alexandria Real Estate Equities

ARE

Alexandria Real Estate Equities, Inc. is a specialized REIT that pioneered the life science real estate niche.

Market cap
$9.24B-26.7%
Revenue$2.9B-5.4%
Net income-$1.1B-615%
Free cash flow$1.1B-0.4%
EPS (diluted)-$6.27-397%
Trailing twelve months · change vs. prior year

Earnings

Next report

Oct 26, 2026 (in 3 months)
Revenue estimate$444.6M
EPS estimate$0.00

Financials

Q1 2026

Income statement

See full
Revenue$671.0M-11.5%
Net income$361.7M+4,146%
EPS (diluted)$2.10+3,100%

Balance sheet

See full
Cash & equivalents$418.7M-12.1%
Total debt$358.6M-3.4%
Total equity$15.7B-9.9%
Total assets$34.2B-9.1%

Cash flow

See full
Operating cash flow$196.6M-5.4%
CapEx$137.6M-6.4%
Free cash flow$59.0M-3.1%

Valuation & ratios

Valuation

See full
Market cap$9.24B-26.7%
Enterprise value$9.18B-29.4%
P/S3.1×-1.1×

Profitability

See full
Net margin-36%-42.7pp
FCF margin36.5%+1.8pp

Returns & leverage

See full
Return on equity-6.4%-7.5pp
Debt / equity0.0×

Segments

By segment

See full
Reportable Segment, Aggregation before Other Operating Segment$625.8M-11.3%
Other Operating Segment$45.2M-13.7%

By product

See full
Income from rentals$621.3M-11.1%

Competitors

Profile

Alexandria Real Estate Equities, Inc. is a specialized REIT that pioneered the life science real estate niche. The company owns, operates, and develops collaborative Megacampus ecosystems in high-demand innovation clusters, providing mission-critical infrastructure for the life science and technology sectors. Its value proposition centers on high-quality Class A/A+ properties that facilitate talent retention and scientific productivity for a diverse base of research-oriented tenants.

Competitive position

Alexandria is the preeminent and longest-tenured owner and operator in the life science real estate niche, maintaining a dominant position in AAA innovation clusters.

GeographiesNorth America, United States
Customer segmentsPharmaceutical Companies, Biotechnology Companies, Research Institutions, Government Agencies
Business modelLeasing, Property Development, Venture Capital
SuppliersConstruction contractors, Architectural firms, Municipal planning departments, Financial lending institutions
CustomersBiopharmaceutical researchers, Medical device manufacturers, Venture capital-backed startups, Academic scientists
Listed1997
Employees568.0
CEOPeter Moglia
Websiteare.com
FilingsSEC EDGAR

FAQ

What is Alexandria Real Estate Equities's market cap?
Alexandria Real Estate Equities (ARE) has a market capitalization of $9.2B and trades on NYSE.
What is Alexandria Real Estate Equities's revenue and profitability?
Alexandria Real Estate Equities generated $2.9B in trailing twelve-month revenue with a net loss of $1.1B, representing a net margin of -36.0%, with free cash flow of $1.1B. These figures are based on the Q1 2026 filing.
Who are Alexandria Real Estate Equities's competitors?
Alexandria Real Estate Equities's key competitors include Boston Properties, Inc., Healthpeak Properties, Inc., Kilroy Realty Corp., and others. These companies compete in similar markets and product categories.
What subsidiaries does Alexandria Real Estate Equities have?
Alexandria Real Estate Equities's subsidiaries include Alexandria Venture Investments.
Where is Alexandria Real Estate Equities headquartered?
Alexandria Real Estate Equities is headquartered in United States of America and employs approximately 568 people. It has been publicly traded since 1997.